Skip to main content
AAPL-0.09%MSFT-0.05%NVDA-0.03%GOOGL-4.07%AMZN+0.05%TSM-6.34%SPCX-1.26%META-0.27%AVGO-3.92%TSLA-0.30%LLY-0.82%BRK-B-0.02%WMT+0.25%JPM-2.31%SKHY-7.29%AMD-5.58%MU+0.13%V+0.16%XOM-2.12%JNJ-1.12%MA+0.08%ASMLa-2.51%ABBV-0.16%COST+0.68%1398.HK+2.15%0700.HK+0.98%KO+0.23%CVX-1.23%PG+1.96%CSCO-1.17%UNH+1.12%ORCL-5.03%0939.HK+1.71%3988.HK+1.59%HD-0.34%BAC-1.84%GE-2.00%1816.HK+2.57%0857.HK+0.58%1288.HK+1.60%0005.HK+0.43%PM-1.47%HSBA.L-0.37%NVS-0.19%INTC-7.07%MS-2.65%AZN-0.23%AP2d-0.61%AMAT-5.47%TXN-3.09%AUDJPY-0.69%NZDJPY-0.67%AUDUSD-0.54%NZDUSD-0.50%GBPTRY+0.41%AUDCHF-0.41%EURJPY-0.40%NZDCHF-0.38%GBPJPY-0.36%CADJPY-0.36%AUDCAD-0.34%GBPHKD+0.32%GBPAUD+0.32%NZDCAD-0.32%EURAUD+0.31%GBPNZD+0.31%CHFJPY-0.29%GBPMXN-0.28%EURNZD+0.27%EURUSD-0.23%USDCAD+0.20%GBPUSD-0.19%USDJPY-0.17%USDILS+0.16%USDCHF+0.15%USDCNH-0.15%USDTRY+0.08%EURCHF-0.08%CADCHF-0.06%GBPCHF-0.05%AUDNZD-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP-0.03%GBPCAD-0.01%USDHKD+0.01%USDTHB-0.01%NOKJPY0.00%EURPLN0.00%NZDMXN0.00%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURSEK0.00%USDDKK0.00%CHFNOK0.00%EURNOK0.00%NZDSGD0.00%EURCZK0.00%EURDKK0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%UKOIL-4.63%USOIL-4.62%GAGUSD-3.48%XAGUSD-3.47%XPTUSD-2.92%XNGUSD-2.73%HG1-1.26%GAUUSD-0.57%XAUUSD-0.57%COCOA0.00%W10.00%S10.00%BTCUSD-0.06%ETHUSD+56.78%USDTUSD-0.01%XRPUSD+54.01%SOLUSD+62.71%TRXUSDT+0.07%ZECUSDT-0.55%XMRUSDT-0.60%DOGEUSD+56.51%LINKUSD-1.50%XLMUSD-2.70%BCHUSDT-0.47%LTCUSD+46.82%UNIUSD-0.23%TONUSD+59.79%SUIUSD-1.75%HBARUSDT-2.80%TAOUSDT-1.62%AAVEUSD-1.62%ONDOUSDT-1.42%ICPUSDT+13.35%DOTUSDT-0.58%WLDUSDT-2.71%ARBUSDT-2.25%ATOMUSDT+2.32%INJUSDT-0.98%STXUSDT-2.35%PYTHUSDT-6.02%TIAUSDT-1.66%FETUSDT+0.51%SEIUSDT-0.49%JUPUSDT-7.90%OPUSDT-1.77%GRTUSDT-1.64%IOTAUSDT+0.08%POLUSDT-1.82%WIFUSDT+0.71%AXSUSDT-1.45%EOSUSDT+0.59%FARTCOINUSDT-3.10%IMXUSDT-2.11%GALAUSDT-0.22%DYDXUSDT+0.54%ORDIUSDT-0.93%NOTUSDT+3.82%RONINUSDT-2.38%AAPL-0.09%MSFT-0.05%NVDA-0.03%GOOGL-4.07%AMZN+0.05%TSM-6.34%SPCX-1.26%META-0.27%AVGO-3.92%TSLA-0.30%LLY-0.82%BRK-B-0.02%WMT+0.25%JPM-2.31%SKHY-7.29%AMD-5.58%MU+0.13%V+0.16%XOM-2.12%JNJ-1.12%MA+0.08%ASMLa-2.51%ABBV-0.16%COST+0.68%1398.HK+2.15%0700.HK+0.98%KO+0.23%CVX-1.23%PG+1.96%CSCO-1.17%UNH+1.12%ORCL-5.03%0939.HK+1.71%3988.HK+1.59%HD-0.34%BAC-1.84%GE-2.00%1816.HK+2.57%0857.HK+0.58%1288.HK+1.60%0005.HK+0.43%PM-1.47%HSBA.L-0.37%NVS-0.19%INTC-7.07%MS-2.65%AZN-0.23%AP2d-0.61%AMAT-5.47%TXN-3.09%AUDJPY-0.69%NZDJPY-0.67%AUDUSD-0.54%NZDUSD-0.50%GBPTRY+0.41%AUDCHF-0.41%EURJPY-0.40%NZDCHF-0.38%GBPJPY-0.36%CADJPY-0.36%AUDCAD-0.34%GBPHKD+0.32%GBPAUD+0.32%NZDCAD-0.32%EURAUD+0.31%GBPNZD+0.31%CHFJPY-0.29%GBPMXN-0.28%EURNZD+0.27%EURUSD-0.23%USDCAD+0.20%GBPUSD-0.19%USDJPY-0.17%USDILS+0.16%USDCHF+0.15%USDCNH-0.15%USDTRY+0.08%EURCHF-0.08%CADCHF-0.06%GBPCHF-0.05%AUDNZD-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP-0.03%GBPCAD-0.01%USDHKD+0.01%USDTHB-0.01%NOKJPY0.00%EURPLN0.00%NZDMXN0.00%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURSEK0.00%USDDKK0.00%CHFNOK0.00%EURNOK0.00%NZDSGD0.00%EURCZK0.00%EURDKK0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%UKOIL-4.63%USOIL-4.62%GAGUSD-3.48%XAGUSD-3.47%XPTUSD-2.92%XNGUSD-2.73%HG1-1.26%GAUUSD-0.57%XAUUSD-0.57%COCOA0.00%W10.00%S10.00%BTCUSD-0.06%ETHUSD+56.78%USDTUSD-0.01%XRPUSD+54.01%SOLUSD+62.71%TRXUSDT+0.07%ZECUSDT-0.55%XMRUSDT-0.60%DOGEUSD+56.51%LINKUSD-1.50%XLMUSD-2.70%BCHUSDT-0.47%LTCUSD+46.82%UNIUSD-0.23%TONUSD+59.79%SUIUSD-1.75%HBARUSDT-2.80%TAOUSDT-1.62%AAVEUSD-1.62%ONDOUSDT-1.42%ICPUSDT+13.35%DOTUSDT-0.58%WLDUSDT-2.71%ARBUSDT-2.25%ATOMUSDT+2.32%INJUSDT-0.98%STXUSDT-2.35%PYTHUSDT-6.02%TIAUSDT-1.66%FETUSDT+0.51%SEIUSDT-0.49%JUPUSDT-7.90%OPUSDT-1.77%GRTUSDT-1.64%IOTAUSDT+0.08%POLUSDT-1.82%WIFUSDT+0.71%AXSUSDT-1.45%EOSUSDT+0.59%FARTCOINUSDT-3.10%IMXUSDT-2.11%GALAUSDT-0.22%DYDXUSDT+0.54%ORDIUSDT-0.93%NOTUSDT+3.82%RONINUSDT-2.38%
DA

Danaher Corporation (DHR)

NYSE • Healthcare

$229.91
-$3.11 (-1.3%)
Market closed

Last close at November 16, 2026 at 21:00 UTC

Open$233.54
Day Range$229.67 - $233.75
Avg. Volume (3M)4M
Market Cap$162.6B
P/E Ratio37.6
52 Week Range
$160.93$242.8
Next EarningsIn 72 daysJan 27, 2027

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$6.5B100%
Gross Profitminus cost of goods$3.8B59%
Operating Incomeminus R&D and overhead$1.2B19%
Net Incomeminus taxes and the rest$1.2B19%

In plain terms: out of every $100 in revenue, Danaher Corporation keeps $19 as net profit.

Fundamentals & Financials

Revenue (TTM)
$25.6B
Net Income (TTM)
$4.3B
EPS (TTM)
$6.12
ROA (TTM)
4.64%
Current Ratio
1.63
Dividend Yield
0.18%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+6.2%Q2 2026$2.06
+4.9%Q3 2026$1.94
+9.9%Q4 2026$2.11
Next

Jan 27

in 72 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +9.9%

Danaher’s preliminary results for the third fiscal quarter of 2026 showed adjusted EPS that topped expectations while revenue came in essentially in line, as reported October 21, 2026 for the period ended September 25, 2026. Revenue rose 8.3% to about $6.6 billion (up from roughly $6.1 billion a year ago), and on the consensus screen revenue of $6.554 billion was in line with the $6.560 billion estimate (-0.1%). Adjusted EPS was $2.11, up from $1.89 a year ago, and it topped the $1.92 estimate (+9.9%). Profitability for the quarter included gross margin of roughly 59% and operating margin of 19.0%, with operating income of about $1.2 billion. Net income climbed 36.0% to roughly $1.2 billion versus about $908 million a year ago, and the company generated operating cash flow of around $1.9 billion. For the next period, consensus calls for EPS of $2.52 on revenue of $7.520 billion.

View full earnings history

About Danaher Corporation

Danaher Corporation trades on the NYSE under DHR and operates across life science and medical technology tools, diagnostics, and applied instrumentation. In FY2025, Danaher generated $24.6 billion in revenue. Its business spans research instruments, clinical testing systems, and water and packaging-related technologies sold to customers around the world.

Name
Danaher Corporation
CEO
Julie Sawyer Montgomery
Industry
Healthcare
Year Founded
1969
Employees
59,000

Today's Snapshot

AI-generated

The day ended with DHR 1.2% lower at 230.15, while its sector was flat. Danaher's diagnostics unit Cepheid won EU clearance for a respiratory test panel.

Trading Volume

Below 10d avg (3.4M)

3.2M

vs S&P 500 Today

Outperforming Market

+0.67%

Updated: November 16, 2026 at 21:31 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
DHR’s technical profile leans constructive as the stock trades just under near-term averages but remains well above its 50/100/200-day levels, showing longer-term support. Momentum is modestly positive and MACD is flat to mildly constructive, while ADX in the mid-20s suggests a developing but not dominant trend. Average true range is moderate and on-balance volume is supportive, although the classic pivot sits slightly above the current price. These converging elements account for a buy tilt without an overextended read. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$211.30 - $232.23
    Buy
  • RSI (14)51.07
    Neutral
  • Stochastic %K (14, 3, 3)56.80
    Neutral
  • MACD Level (12, 26)2.59
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.